ID

33874

Description

Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Mots-clés

Versions (1)
  1. 05/01/2019 05/01/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

5 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B

Anglais

Study Conclusion

1 Formulaires  
  1. StudyEvent: ODM
    1. Study Conclusion
Study Conclusion
Description

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Has the subject become pregnant during the study?
Description

Pregnant During the Study

Type de données

text

Alias
UMLS CUI [1]
C3828490
Has the code been broken?
Description

Clinical Research, Code

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0805701
Did any elimination criteria become applicable during the study?
Description

Exclusion Criteria, Applicable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1706839
Has the subject dropped out of the study? (a drop out is a subject who did not come back for the concluding visit foreseen in the protocol.)
Description

Study Subject Participation Status, Withdrawal by Subject

Type de données

text

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1710677
Date of last contact
Description

Withdraw, Date last contact

Type de données

date

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0805839
Was the subject in good condition at date of last contact?
Description

Withdraw, Date last contact, Condition

Type de données

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0805839
UMLS CUI [1,3]
C1142435
Investigator Signature
Description

Investigator Signature

Alias
UMLS CUI-1
C2346576
Date
Description

I certify that I have reviewed the data in this case report form, the Adverse Events and Serious Adverse Event sections including any laboratory data (if appropriate) and that all information is complete and accurate.

Type de données

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Investigator Signature
Description

Investigator Signature

Type de données

text

Alias
UMLS CUI [1]
C2346576
Retour au début de la page

Similar models

Study Conclusion

1 Formulaires
  1. StudyEvent: ODM
    1. Study Conclusion
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Item
Has the subject become pregnant during the study?
text
C3828490 (UMLS CUI [1])
Pregnant During the Study
Code List
Has the subject become pregnant during the study?
CL Item
No (1)
CL Item
Yes, please complete the Pregnancy Report Form. ™  (™2)
CL Item
NA (3)
Clinical Research, Code
Item
Has the code been broken?
boolean
C0008972 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
Exclusion Criteria, Applicable
Item
Did any elimination criteria become applicable during the study?
boolean
C0680251 (UMLS CUI [1,1])
C1706839 (UMLS CUI [1,2])
Item
Has the subject dropped out of the study? (a drop out is a subject who did not come back for the concluding visit foreseen in the protocol.)
text
C2348568 (UMLS CUI [1,1])
C1710677 (UMLS CUI [1,2])
Study Subject Participation Status, Withdrawal by Subject
Code List
Has the subject dropped out of the study? (a drop out is a subject who did not come back for the concluding visit foreseen in the protocol.)
CL Item
No (1)
CL Item
Yes, Serious adverse event (complete the Serious Adverse Event form) (SAE) (2)
CL Item
Yes, Non-serious adverse event, (complete the Non-Serious Adverse Events section), (3)
CL Item
please specify AE No. (AEX) (please specify AE No. (AEX))
CL Item
Yes, Protocol violation, please specify (PTV) (4)
CL Item
Yes, Consent withdrawal, not due to an adverse event (CWS) (5)
CL Item
Yes, ™Migrated / moved from the study area (MIG) (6)
CL Item
Yes, ™Lost to follow-up (LFU) (7)
CL Item
Yes, Others, please specify (OTH) (8)
Withdraw, Date last contact
Item
Date of last contact
date
C2349954 (UMLS CUI [1,1])
C0805839 (UMLS CUI [1,2])
Item
Was the subject in good condition at date of last contact?
text
C2349954 (UMLS CUI [1,1])
C0805839 (UMLS CUI [1,2])
C1142435 (UMLS CUI [1,3])
Withdraw, Date last contact, Condition
Code List
Was the subject in good condition at date of last contact?
CL Item
Yes (2)
CL Item
No, please give details within the Adverse Events section ™  (™1)
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Investigator Signature, Date in time
Item
Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial